Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Nationwide reported record sales for the fourth consecutive year: $68.5 million in 2024, a 13% increase from the prior year ...